Effect of Cannabidiol in LPS-induced toxicity in astrocytes: Possible role for cannabinoid type-1 receptors
Authors:
Preprint
- 31 January 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Cerebral metabolic abnormalities are common in neurodegenerative diseases. Previous studies have shown that mitochondrial damage alters ATP production and increases Reactive Oxygen Species (ROS) release which may contribute to neurodegeneration. In the present study, we investigated the neuroprotective effects of cannabidiol (CBD), a non-psychoactive component derived from marijuana (Cannabis sativa L.), on astrocytic bioenergetic balance; in a primary cell culture model of lipopolysaccharide (LPS)-induced neurotoxicity. Astrocytic metabolic profiling using an extracellular flux analyzer demonstrated that CBD decreases mitochondrial proton leak, increased spare respiratory capacity and coupling efficiency in LPS-stimulated astrocytes. Simultaneously CBD increased astrocytic glycolytic capacity and glycolysis reserve in a cannabinoid receptor type 1 (CB1) dependent manner. CBD-restored metabolic changes were correlated with a significant decrease in the pro-inflammatory cytokines tumor necrosis factor (TNF) and interleukin-6 (IL-6) concentration, and a reduction of ROS production in LPS-stimulated astrocytes. These results suggest that CBD may inhibit LPS-induced metabolic impairments and inflammation by enhancing astrocytic metabolic glycolysis versus oxidative phosphorylation through its action on CB1 receptors. The present findings suggest CBD as a potential anti-inflammatory treatment in metabolic pathologies and highlight a possible role for the cannabinoidergic system in the modulation of mitochondrial oxidative stress.Keywords
All Related Versions
- Version 1, 2023-01-31, Research Square
- Published version: Neurotoxicity Research, 41 (6), 615.
This publication has 56 references indexed in Scilit:
- Genomic Analysis of Reactive AstrogliosisThe Journal of Neuroscience, 2012
- Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ InvolvementPLOS ONE, 2011
- Inflammation in the early stages of neurodegenerative pathologyJournal of Neuroimmunology, 2011
- Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88‐dependent NFκB signaling, MAPK, and Jak1/Stat1 pathwaysGlia, 2010
- Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial CellsJournal of Biological Chemistry, 2010
- Regulatory Role of TLR Ligands on the Activation of Autoreactive T Cells by Retinal AstrocytesInvestigative Ophthalmology & Visual Science, 2009
- Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+LevelsThe Journal of Neuroscience, 2009
- Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyondAddiction Biology, 2008
- Kinetics of inflammatory response of astrocytes induced by TLR 3 and TLR4 ligationJournal of Neuroscience Research, 2006
- Structure of Cannabidiol, a Product Isolated from the Marihuana Extract of Minnesota Wild Hemp. IJournal of the American Chemical Society, 1940